Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Dermatol Ther
; 35(2): e15231, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34820971
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Dermatol Ther
Journal subject:
DERMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
España
Country of publication:
Estados Unidos